{"count": 8, "results": [{"_id": "32010989", "pmid": 32010989, "title": "The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet.", "journal": "J Food Biochem", "authors": ["Koubaa-Ghorbel F", "Chaâbane M", "Turki M", "Makni-Ayadi F", "El Feki A"], "date": "2020-04-01T00:00:00Z", "doi": "10.1111/jfbc.13160", "meta_date_publication": "2020 Apr", "meta_volume": "44", "meta_issue": "4", "meta_pages": "e13160", "score": 50247.734, "text_hl": "All animals were sacrificed after 8 weeks of treatment. SEO and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced in HFD @SPECIES_10090 @@@mice@@@ body @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@, @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@, disruption of liver @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@and renal@@@ functions and @CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@reactive oxygen species@@@ production. ", "citations": {"NLM": "Koubaa-Ghorbel F, Chaâbane M, Turki M, Makni-Ayadi F, El Feki A. The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet. J Food Biochem. 2020 Apr;44(4):e13160. PMID: 32010989", "BibTeX": "@article{32010989, title={The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet.}, author={Koubaa-Ghorbel F and Chaâbane M and Turki M and Makni-Ayadi F and El Feki A}, journal={J Food Biochem}, volume={44}, number={4}, pages={e13160}}"}}, {"_id": "21291693", "pmid": 21291693, "title": "Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia.", "journal": "J Clin Lipidol", "authors": ["Stein EA", "Marais AD", "Ducobu J", "Farnier M", "Gavish D", "Hauner H", "Kaplan AJ", "Le Maulf F", "Melezínková H"], "date": "2007-08-01T00:00:00Z", "doi": "10.1016/j.jacl.2007.07.004", "meta_date_publication": "2007 Aug", "meta_volume": "1", "meta_issue": "4", "meta_pages": "287-99", "score": 50067.105, "text_hl": "Comparison of short-term @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@renal@@@ effects and efficacy of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ 40 mg and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 80 mg, followed by assessment of long-term @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@renal@@@ effects of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ 40 mg, in @SPECIES_9606 @@@patients@@@ with @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@.", "citations": {"NLM": "Stein EA, Marais AD, Ducobu J, Farnier M, Gavish D, Hauner H, Kaplan AJ, Le Maulf F, Melezínková H. Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia. J Clin Lipidol. 2007 Aug;1(4):287-99. PMID: 21291693", "BibTeX": "@article{21291693, title={Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia.}, author={Stein EA and Marais AD and Ducobu J and Farnier M and Gavish D and Hauner H and Kaplan AJ and Le Maulf F and Melezínková H}, journal={J Clin Lipidol}, volume={1}, number={4}, pages={287-99}}"}}, {"_id": "20936727", "pmid": 20936727, "title": "[Effects of simvastatin on expression of CTGF and alpha-SMA in renal tubulointerstitium of rats with diabetic nephropathy].", "journal": "Zhejiang Da Xue Xue Bao Yi Xue Ban", "authors": ["Lin FL", "Shen HC", "Zhu B", "Lin KQ"], "date": "2010-09-01T00:00:00Z", "doi": "10.3785/j.issn.1008-9292.2010.05.012", "meta_date_publication": "2010 Sep", "meta_volume": "39", "meta_issue": "5", "meta_pages": "511-6", "score": 50063.887, "text_hl": "[Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on expression of @GENE_CCN2 @GENE_64032 @@@CTGF@@@ and alpha-SMA in @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@renal tubulointerstitium@@@ of @SPECIES_10116 @@@rats@@@ with @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@].", "citations": {"NLM": "Lin FL, Shen HC, Zhu B, Lin KQ. [Effects of simvastatin on expression of CTGF and alpha-SMA in renal tubulointerstitium of rats with diabetic nephropathy]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Sep;39(5):511-6. PMID: 20936727", "BibTeX": "@article{20936727, title={[Effects of simvastatin on expression of CTGF and alpha-SMA in renal tubulointerstitium of rats with diabetic nephropathy].}, author={Lin FL and Shen HC and Zhu B and Lin KQ}, journal={Zhejiang Da Xue Xue Bao Yi Xue Ban}, volume={39}, number={5}, pages={511-6}}"}}, {"_id": "26157709", "pmid": 26157709, "pmcid": "PMC4476217", "title": "ATP-dependent potassium channels are implicated in simvastatin pretreatment-induced inhibition of apoptotic cell death after renal ischemia/reperfusion injury", "journal": "Med J Islam Repub Iran", "authors": ["Dowlatshahi K", "Ajami M", "Pazoki-Toroudi H", "Hajimiresmaiel SJ"], "date": "2015-03-14T00:00:00Z", "meta_date_publication": "2015", "meta_volume": "29", "meta_issue": "", "meta_pages": "191", "score": 50060.137, "text_hl": "This implies to the role of KATP ion channels by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in the @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@renal@@@ protection after @DISEASE_Reperfusion_Injury @DISEASE_MESH:D015427 @@@I/R injury@@@. ", "citations": {"NLM": "Dowlatshahi K, Ajami M, Pazoki-Toroudi H, Hajimiresmaiel SJ. ATP-dependent potassium channels are implicated in simvastatin pretreatment-induced inhibition of apoptotic cell death after renal ischemia/reperfusion injury Med J Islam Repub Iran. 2015;29():191. PMID: 26157709", "BibTeX": "@article{26157709, title={ATP-dependent potassium channels are implicated in simvastatin pretreatment-induced inhibition of apoptotic cell death after renal ischemia/reperfusion injury}, author={Dowlatshahi K and Ajami M and Pazoki-Toroudi H and Hajimiresmaiel SJ}, journal={Med J Islam Repub Iran}, volume={29}, pages={191}}"}}, {"_id": "26492285", "pmid": 26492285, "title": "Simvastatin attenuates oleic acid-induced oxidative stress through CREB-dependent induction of heme oxygenase-1 in renal proximal tubule cells.", "journal": "Pediatr Res", "authors": ["Barnett M", "Hall S", "Dixit M", "Arany I"], "date": "2016-02-01T00:00:00Z", "doi": "10.1038/pr.2015.210", "meta_date_publication": "2016 Feb", "meta_volume": "79", "meta_issue": "2", "meta_pages": "243-50", "score": 50058.773, "text_hl": "We hypothesize that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@) transcriptionally activates @GENE_HMOX1 @GENE_24451 @@@HO-1@@@ that protects @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@renal@@@ proximal tubule cells from @DISEASE_Wounds_and_Injuries @DISEASE_MESH:D014947 @@@lipotoxic injury@@@. ", "citations": {"NLM": "Barnett M, Hall S, Dixit M, Arany I. Simvastatin attenuates oleic acid-induced oxidative stress through CREB-dependent induction of heme oxygenase-1 in renal proximal tubule cells. Pediatr Res. 2016 Feb;79(2):243-50. PMID: 26492285", "BibTeX": "@article{26492285, title={Simvastatin attenuates oleic acid-induced oxidative stress through CREB-dependent induction of heme oxygenase-1 in renal proximal tubule cells.}, author={Barnett M and Hall S and Dixit M and Arany I}, journal={Pediatr Res}, volume={79}, number={2}, pages={243-50}}"}}, {"_id": "17878758", "pmid": 17878758, "title": "Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.", "journal": "J Cardiovasc Pharmacol", "authors": ["Rugale C", "Delbosc S", "Mimran A", "Jover B"], "date": "2007-09-01T00:00:00Z", "doi": "10.1097/FJC.0b013e3180a72606", "meta_date_publication": "2007 Sep", "meta_volume": "50", "meta_issue": "3", "meta_pages": "293-8", "score": 50047.23, "text_hl": "Our results indicate that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reverse established @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@cardiac and renal alterations@@@ in @GENE_AGT @GENE_24179 @@@AngII@@@ @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ independently of arterial pressure. ", "citations": {"NLM": "Rugale C, Delbosc S, Mimran A, Jover B. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine. J Cardiovasc Pharmacol. 2007 Sep;50(3):293-8. PMID: 17878758", "BibTeX": "@article{17878758, title={Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.}, author={Rugale C and Delbosc S and Mimran A and Jover B}, journal={J Cardiovasc Pharmacol}, volume={50}, number={3}, pages={293-8}}"}}, {"_id": "20377476", "pmid": 20377476, "title": "Ezetimibe and recent clinical trials: a look on the bright side.", "journal": "Expert Opin Drug Saf", "authors": ["Ahmed MH"], "date": "2010-07-01T00:00:00Z", "doi": "10.1517/14740331003702376", "meta_date_publication": "2010 Jul", "meta_volume": "9", "meta_issue": "4", "meta_pages": "511-4", "score": 50046.18, "text_hl": "The SHARP trial (Study of Heart @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@And Renal@@@ Protection) will evaluate the effects of lowering low-density lipoprotein cholesterol with @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg/day versus placebo in @SPECIES_9606 @@@patients@@@ with @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease@@@. ", "citations": {"NLM": "Ahmed MH. Ezetimibe and recent clinical trials: a look on the bright side. Expert Opin Drug Saf. 2010 Jul;9(4):511-4. PMID: 20377476", "BibTeX": "@article{20377476, title={Ezetimibe and recent clinical trials: a look on the bright side.}, author={Ahmed MH}, journal={Expert Opin Drug Saf}, volume={9}, number={4}, pages={511-4}}"}}, {"_id": "23754124", "pmid": 23754124, "title": "A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.", "journal": "Drugs", "authors": ["Alla VM", "Agrawal V", "DeNazareth A", "Mohiuddin S", "Ravilla S", "Rendell M"], "date": "2013-07-01T00:00:00Z", "doi": "10.1007/s40265-013-0072-9", "meta_date_publication": "2013 Jul", "meta_volume": "73", "meta_issue": "10", "meta_pages": "1025-54", "score": 50028.285, "text_hl": "@DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@Myopathy@@@ and @<m>DISEASE_Glycosuria_Renal</m> @DISEASE_MESH:D006030 @@@renal@@@ events have been a significant concern with the use of high potency statin drugs, in particular @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@. ", "citations": {"NLM": "Alla VM, Agrawal V, DeNazareth A, Mohiuddin S, Ravilla S, Rendell M. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs. Drugs. 2013 Jul;73(10):1025-54. PMID: 23754124", "BibTeX": "@article{23754124, title={A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.}, author={Alla VM and Agrawal V and DeNazareth A and Mohiuddin S and Ravilla S and Rendell M}, journal={Drugs}, volume={73}, number={10}, pages={1025-54}}"}}]}